TABLE 3.
Demographic and clinical characteristics of oropharyngeal cancer patients with negative and positive SEC61G
| Categories | Level | SEC61G expression | ||
|---|---|---|---|---|
| Negative (n = 33) | Positive (n = 58) | p‐value | ||
| Gender | Female | 6 | 5 | 0.197 |
| Male | 27 | 53 | ||
| Age (year) | <60 | 18 | 34 | 0.706 |
| ≥60 | 15 | 24 | ||
| T classification | T1–T2 | 18 | 29 | 0.737 |
| T3–T4 | 15 | 28 | ||
| N classification | N0–1 | 11 | 15 | 0.448 |
| N2–3 | 22 | 43 | ||
| Clinical stage | I–II | 4 | 16 | 0.087 |
| III–IV | 29 | 42 | ||
| Smoking | No | 11 | 22 | 0.513 |
| Yes | 21 | 31 | ||
| Differentiated | Poor | 9 | 8 | 0.193 |
| Moderately | 17 | 30 | ||
| Well | 7 | 20 | ||
| Keratinization | No | 14 | 10 | 0.009 |
| Yes | 19 | 48 | ||
| Treatment | RT ± CT | 21 | 31 | 0.345 |
| Surgery ± RT ± CT | 12 | 27 | ||
Abbreviations: CT, chemotherapy; RT, radiotherapy.